20 April 2012 In vivo fluorescence lifetime detection of an activatable probe in infarcted myocardium
Author Affiliations +
Abstract
Activatable fluorescent molecular probes are predominantly nonfluorescent in their inactivated state due to intramolecular quenching, but increase fluorescence yield significantly after enzyme-mediated hydrolysis of peptides. Continuous wave in vivo detection of these protease-activatable fluorophores in the heart, however, is limited by the inability to differentiate between activated and nonactivated fractions of the probe and is frequently complicated by large background signal from probe accumulation in the liver. Using a cathepsin-activatable near-infrared probe (PGC-800), we demonstrate here that fluorescence lifetime (FL) significantly increases in infarcted murine myocardial tissue (0.67 ns) when compared with healthy myocardium (0.59 ns) after 24 h. Furthermore, we show that lifetime contrast can be used to distinguish in vivo cardiac fluorescence from background nonspecific liver signal. The results of this study show that lifetime contrast is a helpful addition to preclinical imaging of activatable fluorophores in the myocardium by reporting molecular activity in vivo due to changes in intramolecular quenching. This characterization of FL from activatable molecular probes will be helpful for advancing in vivo imaging of enzyme activity.
© 2012 Society of Photo-Optical Instrumentation Engineers (SPIE)
Craig J. Goergen, Craig J. Goergen, Anand T. N. Kumar, Anand T. N. Kumar, Howard H. Chen, Howard H. Chen, Alexei Bogdanov, Alexei Bogdanov, David E. Sosnovik, David E. Sosnovik, } "In vivo fluorescence lifetime detection of an activatable probe in infarcted myocardium," Journal of Biomedical Optics 17(5), 056001 (20 April 2012). https://doi.org/10.1117/1.JBO.17.5.056001 . Submission:
JOURNAL ARTICLE
7 PAGES


SHARE
Back to Top